The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
Open accessAbstract
Alpha-fetoprotein (AFP) is an oncofetal glycoprotein that has been used as a tumor marker for hepatocellular carcinoma (HCC) in combination with ultrasound and other imaging modalities. Its utility is limited because of both low sensitivity and specificity, and discrepancies among the different methods of measurements. Moreover, its accuracy varies according to patient characteristics and the AFP cut-off values used. Combination of AFP with novel biomarkers such as AFP-L3, Golgi specific membrane protein (GP73) and des-gamma-carboxyprothrombin significantly improved its accuracy in detecting HCC. Increased AFP level could also signify severity of hepatic destruction and subsequent regeneration and is commonly observed in patients with acute and chronic liver conditions and cirrhosis. Hereditary and other non-hepatic disorders can also cause AFP elevation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Tzartzeva, K., Obi, J., Rich, N. E., Parikh, N. D., Marrero, J. A., Yopp, A., Waljee, A. K., & Singal, A. G. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.064 · Cited by 1,207
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Singal, A. G., Lampertico, P., & Nahon, P. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.025 · Cited by 1,102
PRODUCTION OF EMBRYONAL α-GLOBULIN BY TRANSPLANTABLE MOUSE HEPATOMAS
Abelev, G. I., Perova, S. D., KHRAMKOVA, N. I., POSTNIKOVA, Z. A., & Irlin, I. S. (1963) · Transplantation · doi:10.1097/00007890-196301020-00004 · Cited by 595
Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus.
Gitlin, D., Perricelli, A., & Gitlin, G. M. (1972) · PubMed · Cited by 549
Gupta, S., Bent, S., & Kohlwes, J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00012 · Cited by 420
Shen, Q., Fan, J., Yang, X.-R., Tan, Y., Zhao, W., Xu, Y., Wang, N., Niu, Y., Wu, Z., Zhou, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70233-4 · Cited by 394
α-fetoprotein: Reevaluation in hepatology
Taketa, K. (1990) · Hepatology · doi:10.1002/hep.1840120625 · Cited by 353
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
Di Bisceglie, A. M., Sterling, R. K., Chung, R. T., Everhart, J. E., Dienstag, J. L., Bonkovsky, H. L., Wright, E. C., Everson, G. T., Lindsay, K. L., Lok, A. S. F., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.019 · Cited by 350
Nomura, F., Ohnishi, K., & Tanabe, Y. (1989) · Cancer · doi:10.1002/1097-0142(19891015)64:8<1700::aid-cncr2820640824>3.0.co;2-z · Cited by 305
Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management
Chang, M.-L., & Liaw, Y.-F. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.033 · Cited by 296
Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma
Sauzay, C., Petit, A., Bourgeois, A.-M., Barbare, J.-C., Chauffert, B., Galmiche, A., & Houessinon, A. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.10.006 · Cited by 291
Best, J., Bechmann, L. P., Sowa, J.-P., Sydor, S., Dechêne, A., Pflanz, K., Bedreli, S., Schotten, C., Geier, A., Berg, T., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.11.012 · Cited by 288
Luo, P., Wu, S., Yu, Y., Ming, X., Li, S., Zuo, X., & Tu, J. (2020) · Pathology & Oncology Research · doi:10.1007/s12253-019-00585-5 · Cited by 236
Taketa, K., Sekiya, C., Namiki, M., 赤松, 興., Ohta, Y., Endo, Y., & Kosaka, K. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91034-4 · Cited by 212
Sonbol, M. B., Riaz, I. B., Naqvi, S. A. A., Almquist, D. R., Mina, S., Almasri, J., Shah, S., Almader-Douglas, D., Uson Junior, P. L. S., Mahipal, A., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.4930 · Cited by 197
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis
Thompson Coon, J., Rogers, G., Hewson, P., Wright, D., Anderson, R., Cramp, M., Jackson, S., Ryder, S., Price, A., & Stein, K. (2007) · Health Technology Assessment · doi:10.3310/hta11340 · Cited by 195
Gambarin-Gelwan, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00883-2 · Cited by 184
Alpha-fetoprotein: a renaissance
Terentiev, A. A., & Moldogazieva, N. T. (2013) · Tumor Biology · doi:10.1007/s13277-013-0904-y · Cited by 181
Epidemiology and Surveillance of Hepatocellular Carcinoma
Kim, D. Y., & Han, K.-H. (2012) · Liver Cancer · doi:10.1159/000339016 · Cited by 181
Hepatocellualar Carcinoma Serum Markers
Bertino, G., Ardiri, A., Malaguarnera, M., Malaguarnera, G., Bertino, N., & Calvagno, G. S. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.001 · Cited by 167
Toyoda, H., Kumada, T., Tada, T., Sone, Y., Kaneoka, Y., & Maeda, A. (2015) · Liver Cancer · doi:10.1159/000367735 · Cited by 166
Cost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms
Parikh, N. D., Singal, A. G., Hutton, D. W., & Tapper, E. B. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000715 · Cited by 163
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
Wang, X., & Wang, Q. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/9049252 · Cited by 162
Wong, R. J., Ahmed, A., & Gish, R. G. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.005 · Cited by 153
Oka, H., Saito, A., Ito, K., Kumada, T., Satomura, S., Kasugai, H., Osaki, Y., Seki, T., Kudo, M., & Tanaka, M. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02643.x · Cited by 143
Leerapun, A., Suravarapu, S. V., Bida, J. P., Clark, R. J., Sanders, E. L., Mettler, T. A., Stadheim, L. M., Aderca, I., Moser, C. D., Nagorney, D. M., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.005 · Cited by 138
Law, S. W. T., & Dugaiczyk, A. (1981) · Nature · doi:10.1038/291201a0 · Cited by 130
Novel biomarkers for the management of chronic hepatitis B
Inoue, T., & Tanaka, Y. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0032 · Cited by 126
Rapid and sensitive chemiluminescent enzyme immunoassay for measuring tumor markers
Nishizono, I., Iida, S., Suzuki, N., Kawada, H., Murakami, H., Ashihara, Y., & Okada, M. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.9.1639 · Cited by 124
Crandall, B. F., & Lau, H. L. (1981) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368109105870 · Cited by 113
Chen, T., Huang, P., Tsai, M., Lin, L., Liu, C., Ho, K., Siauw, C., Chao, P., & Tung, J. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04898.x · Cited by 93
Yu, R., Tan, Z., Xiang, X., Dan, Y., & Deng, G. (2017) · BMC Cancer · doi:10.1186/s12885-017-3609-6 · Cited by 89
Lim, T. S., Kim, D. Y., Han, K., Kim, H.-S., Shin, S., Jung, K. S., Kim, B. K., Kim, S. U., Park, J. Y., & Ahn, S. H. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1082190 · Cited by 87
Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein
Agopian, V. G., Harlander‐Locke, M. P., Markovic, D., Zarrinpar, A., Kaldas, F. M., Cheng, E. Y. L., Yersiz, H., Farmer, D. G., Hiatt, J. R., & Busuttil, R. W. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.3310 · Cited by 85
Yu, J., Han, J., Zhang, J., Li, G., Liu, H., Cui, X., Xu, Y., Li, T., Liu, J., & Wang, C. (2016) · Medicine · doi:10.1097/md.0000000000004436 · Cited by 79
Caviglia, G. P., Abate, M. L., Petrini, E., Gaia, S., Rizzetto, M., & Smedile, A. (2015) · Hepatology Research · doi:10.1111/hepr.12544 · Cited by 70
Stekhin, A., Yakovleva, G., Pronko, K., & Zemskov, V. (2018) · Clinical Practice · doi:10.4172/clinical-practice.1000393 · Cited by 66
Wang, X., Zhang, Y., Yang, N., He, H., Tao, X., Kou, C., & Jiang, J. (2020) · BioMed Research International · doi:10.1155/2020/5087643 · Cited by 66
An Update of Biochemical Markers of Hepatocellular Carcinoma
Alsalloom, A. A. (2016) · International Journal of Health Sciences · doi:10.12816/0031219 · Cited by 64
Pennisi, G., Celsa, C., Giammanco, A., Spatola, F., & Petta, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225613 · Cited by 59
Hereditary persistence of α-fetoprotein
Schefer, H., Mattmann, S., & Joss, R. (1998) · Annals of Oncology · doi:10.1023/a:1008243311122 · Cited by 56
Serum alpha-fetoprotein levels in acute viral hepatitis
Kew, M. C., Purves, L. R., & Bersohn, I. (1973) · Gut · doi:10.1136/gut.14.12.939 · Cited by 55
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Sumida, Y., Yoneda, M., Seko, Y., Ishiba, H., Hara, T., Toyoda, H., Yasuda, S., Kumada, T., Hayashi, H., Kobayashi, T., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10080579 · Cited by 36
Fang, Y.-S., Wu, Q., Zhao, H., Zhou, Y., Ye, L., Liu, S., Li, X., & Du, W. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1900731 · Cited by 34
Surveillance and Diagnosis of Hepatocellular Carcinoma
Lim, J., & Singal, A. G. (2019) · Clinical Liver Disease · doi:10.1002/cld.761 · Cited by 33
Hepatitis B Virus Reactivation
Ekpanyapong, S., & Reddy, K. R. (2020) · Clinics in Liver Disease · doi:10.1016/j.cld.2020.04.002 · Cited by 31
Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk
Kubota, N., Fujiwara, N., & Hoshida, Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123843 · Cited by 21
Song, G., Rao, H., Feng, B., & Wei, L. (2014) · Journal of Medical Virology · doi:10.1002/jmv.24032 · Cited by 16
Peng, C., Li, Z., Xie, Z., Wang, Z., Ye, Y., Li, B., & Li, W. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01345-5 · Cited by 8
Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients
Noritake, H., Kobayashi, Y., Ooba, Y., Kitsugi, K., Shimoyama, S., Yamazaki, S., Chida, T., Watanabe, S., Kawata, K., & Suda, T. (2014) · ISRN Hepatology · doi:10.1155/2014/875140 · Cited by 4
Cited by
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Chan, Y.-T., Zhang, C., Wu, J., Lu, P., Xu, L., Yuan, H., Feng, Y., Chen, Z.-S., & Wang, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02101-z · Cited by 281
Liu, R., Wu, J., Guo, H., Yao, W., Li, S., Lu, Y., Jia, Y., Liang, X., Tang, J., & Zhang, H. (2023) · MedComm · doi:10.1002/mco2.292 · Cited by 264
Glycosylation in cancer: mechanisms, diagnostic markers, and therapeutic applications
Qusairy, Z., & Rada, M. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05303-1 · Cited by 16
Metadata
- Authors
- Hanif, H., Ali, M. J., Susheela, A. T., Khan, I. W., Luna-Cuadros, M. A., Khan, M. M., & Lau, D. T.-Y.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2022-01-14
- Volume
- 28
- Issue
- 2
- Pages
- 216-229
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W4205654760
- Cited by
- 354
- References
- 52
- FWCI
- 33.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.